Indeed, a recent preclinical study demonstrated that TLR7/8 inhibition increased the effect of glucocorticoids in lupus-prone mice and sensitized human PBMC against glucocorticoid treatment [192]. The gene discussed is TLR7; the disease is systemic lupus erythematosus.